Factor V Leiden mutation in postthrombotic and non-postthrombotic venous ulcers

Archives of Dermatology

Volumn 137, Issue 5, 2001, Pages 599-603

  Hafner, Jürg ^a   Kühne, Andreas ^a   Schär, Beatrice ^b   Bombeli, Thomas ^c   Hauser, Markus ^c   Lüthi, René ^c   Hänseler, Edgar ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; POSTTHROMBOSIS SYNDROME; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; ULCER; VEIN INSUFFICIENCY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FACTOR V; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; MUTATION; THROMBOSIS; VARICOSE ULCER;

EID: 0342961999     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nelzén O, Bergquist D, Lindhagen A. The prevalence of chronic low-limb ulceration has been underestimated: results of a validated population questionnaire. Br J Surg. 1996;83:255-258.
2. Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: the "CEAP" classification. Mayo Clin Proc. 1996;71:338-345.
3. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: part I. Thromb Haemost. 1996;76:651-662.
4. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994;330:517-522.
5. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
6. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertira RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993;342:1503-1506.
7. Munkvad S, Jørgensen M. Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration. Br J Dermatol. 1996; 134:296-298.
8. Maessen-Visch MB, Hamulyak K, Tazelaar DJ, Crombag NH, Neumann HA. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Arch Dermatol. 1999;135:41-44.
9. Grossman D, Heald PW, Wang C, Rinder HM. Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers. J Am Acad Dermatol. 1997;37:409-413.
10. Ribeaudeau F, Senet P, Cayuela JM, et al. A prospective coagulation study including resistance to activated protein C and mutations in factors V and II in venous leg ulcers. Br J Dermatol. 1999;141:259-263.
11. Yao ST. Haemodynamic studies in peripheral arterial disease. Br J Surg. 1970; 52:761-766.
12. Lea Thomas M. Phlebography of the Lower Limb. Edinburgh, Scotland: Churchill Livingstone; 1982.
13. Baldt MM, Böhler K, Zontisch T, et al. Preoperative imaging of lower extremity varicose veins: color coded duplex ultrasound or venography? J Ultrasound Med. 1996;15:143-154.
14. Braun A, Müller B, Rosche AA. Population study of the G1691A mutation (R506Q, FV Leiden) in the human factor V gene that is associated with resistance to activated protein C. Hum Genet. 1996;97:263-264.
15. Hézard N, Cornillet P, Droullé C, Gillot L, Potron G, Nguyen P. Factor V Leiden: detection in whole blood by ASA PCR using an additional mismatch in antepen-ultimate position. Thromb Res. 1997;88:59-66.
16. Bounameaux H. Deep venous thrombosis: an overview. Vasa Suppl. 1988;25: 1-28.
17. Johnson BF, Manzo RA, Bergelin RO, Strandness DE Jr. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one-to six-year follow-up. J Vasc Surg. 1995;21:307-313.
18. Franzeck UK, Schalch I, Bollinger A. On the relationship between changes in the deep veins evaluated by duplex sonography and the postthrombotic syndrome 12 years after deep vein thrombosis. Thromb Haemost. 1997;77:1109-1112.
19. Labropoulos N, Leon M, Geroulakos G, Volteas N, Chan P, Nicolaides AN. Venous hemodynamic abnormalities in patients with leg ulceration. Am J Surg. 1995; 169:572-574.
20. Kistner RL, Kamida CB. 1994 Update on phlebography and varicography. Dermatol Surg. 1995;21:71-76.
21. Magnusson M, Kälebo P, Lukes P, Sivertsson R, Risberg B. Colour Doppler ultrasound in diagnosing venous insufficiency: a comparison to descending phlebography. Eur J Vasc Endovasc Surg. 1995;9:437-443.
22. Eichlisberger R, Frauchiger B, Widmer MT, Widmer L, Jäger K. Spätfolgen der tiefen Venenthrombose: ein 13-jahres Follow-up von 223 Patienten. Vasa. 1994; 23:234-243.
23. Kearon C, Gent M, Hirsh J. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med. 1999;340:901-907.
24. Sarasin F, Bounameaux H. Decision analysis model of prolonged oral anticoagulant treatment in factor V Leiden carriers with first episode of deep vein thrombosis. BMJ. 1998;316:95-99.
25. Sarasin FP, Bounameaux H. Duration of oral anticoagulant therapy after proximal deep vein thrombosis: a decision analysis. Thromb Haemost. 1994;71:286-291.